Publication | Open Access
Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells
37
Citations
34
References
2012
Year
Chronic RAD001 treatment caused resistance development characterised by distinct modification of the integrin-expression profile, driving prostate cancer cells towards high motility.
| Year | Citations | |
|---|---|---|
Page 1
Page 1